Proposed Legislation Would Mandate Medicaid Coverage for Ovulation Enhancing Drugs and Infertility Treatment
Senate Bill 3733, introduced in the New Jersey Senate and General Assembly on March 20, 2023, would require Medicaid to cover the cost of medically necessary ovulation-enhancing drugs and associated medical services for individuals aged 21 to 44 experiencing infertility, subject to federal financial participation. Coverage for ovulation-enhancing drugs and medical services would be limited to three treatment cycles per beneficiary’s lifetime.
For more information, contact:
John D. Fanburg, Chair | 973.403.3107 | email@example.com
Edward Hilzenrath | 973.403.3114 | firstname.lastname@example.org
Vanessa Coleman | 973.364.5208 | email@example.com